• Meet CTI
    • Corporate Strategy
    • Milestones
    • Technologies
    • Our People & Subsidiaries
    • Collaborations & Partnerships
    • FAQ
    • Community Involvement
  • Development
    • Pixantrone
    • OPAXIO™
    • Brostallicin
    • Novel Bisplatinum Analogues
    • Medical Inquiries for Healthcare Professionals
    • Medical Inquiries for Patients & Caregivers
  • Clinical Trials
    • Patient Resources
    • Lung Cancer Clinical Trials
    • Ovarian Cancer Clinical Trials
    • Other Clinical Trials
  • Investors
  • Press Room
    • News
    • Press Kits
    • Media Library
    • Media Contacts
  • Careers
    • Compensation & Benefits
    • Living in Seattle
    • Job Opportunities
  • Italiano
  • Site Map
 
News
Stock
SEC Filings
Events & Webcasts
Investor Updates
Annual Reports
Financial Details
Trading Statistics
Balance Sheet
Income Statement
Cash Flow
Ratios
Corporate Governance
Investor FAQ
Information Request
Email Alerts
Print this page Print this page
Email this page Email this page

Financial Details Snapshot

Revenue & Earnings
Revenue (FY).08
EBIT (Mil) (FY)-83.12
EBITDA (Mil) (FY)-83.12
Net Income Excluding Extraordinary Items (Mil) (FY)-95.40
Net Income Including Extraordinary Items (Mil) (FY)-95.40
Diluted EPS Excluding Extraordinary Items (FY)-.25
Diluted EPS Including Extraordinary Items (FY)-.25
Dividends
Yield (%)--
Dividend Record Date--
Dividend Rate--
Ratios
Price to Revenue (TTM)7,826.56
Price To Cash Flow (TTM)--
Price to Book (MRQ)--
Total Debt to Equity (MRQ) (%)--
Current Ratio (MRQ)--
Growth
5-Year Annual Dividend Growth Rate (%)--
5-Year Annual Revenue Growth Rate (%)-69.35
FY = Fiscal Year MRQ = Most Recent Quarter
mil = Millions TTM = Trailing Twelve Months
Powered by Thomson Reuters


CTI Fact Sheet (201K PDF)
Most Viewed Links
1.Current News Release
2.Comunicati stampa
3.SEC Filings
4.Stock Quote
5.Press Room
© 2009 Cell Therapeutics, Inc. All rights reserved.
Privacy PolicyTerms and ConditionsContact CTI